BlackRock Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
BFA
GT
AAM
SCM
BIT
BlackRock Advisors's EBS Position: Q4 2016 in Review
BlackRock Advisors reduced its Emergent Biosolutions (EBS) stake by 61% in Q4 2016, selling an estimated $1.44M and leaving 31,071 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1849.
BlackRock Advisors first reported a position in EBS in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.9M in Q4 2013. 208 funds tracked by Wall St. Rank hold EBS as of Q4 2016.
- BlackRock Advisors held 31,071 shares of Emergent Biosolutions worth $1.02M as of Q4 2016.
- BlackRock Advisors sold 48,143 Emergent Biosolutions shares in Q4 2016, an estimated $1.44M.
- Emergent Biosolutions made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1849 holding.
- BlackRock Advisors first reported a position in Emergent Biosolutions in Q2 2013 and has held it in 15 quarters since.
- BlackRock Advisors's Emergent Biosolutions position peaked at $6.9M in Q4 2013.
- 208 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2016.
Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.